|
1 Indications And Usage Sarclisa Is Indicated, In Combination With Pomalidomide And Dexamethasone, For The Treatment Of Adult Patients With Multiple Myeloma Who Have Received At Least Two Prior Therapies Including Lenalidomide And A Proteasome Inhibitor. Sarclisa Is A Cd38-Directed Cytolytic Antibody Indicated, In Combination With Pomalidomide And Dexamethasone, For The Treatment Of Adult Patients With Multiple Myeloma Who Have Received At Least Two Prior Therapies Including Lenalidomide And A Proteasome Inhibitor. ( 1 )
|